Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Corrigendum: Increased Appetite Plays a Key Role in Olanzapine-Induced Weight Gain in First-Episode Schizophrenia Patients
Jing Huang, Gangrui Hei, Ye Yang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 21

Showing 21 citing articles:

Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects
Carla Rognoni, Arianna Bertolani, Claudio Jommi
Clinical Drug Investigation (2021) Vol. 41, Iss. 4, pp. 303-319
Open Access | Times Cited: 48
Effects of intermittent theta burst stimulation (iTBS) on appetite change and body weight in inpatients with schizophrenia in China: study protocol for a randomised controlled trial
Yue Qin, Jin Yang, Baoyan Xu, et al.
BMJ Open (2025) Vol. 15, Iss. 4, pp. e090932-e090932
Open Access
The effect of continuous theta burst stimulation on antipsychotic-induced weight gain in first-episode drug-naive individuals with schizophrenia: a double-blind, randomized, sham-controlled feasibility trial
Dongyu Kang, Chuhan Song, Xingjie Peng, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Effect of Bifidobacterium on olanzapine-induced body weight and appetite changes in patients with psychosis
Ye Yang, Yujun Long, Dongyu Kang, et al.
Psychopharmacology (2021) Vol. 238, Iss. 9, pp. 2449-2457
Closed Access | Times Cited: 24
Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort
Georgios Schoretsanitis, Céline Dubath, Claire Grosu, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 531-541
Open Access | Times Cited: 16
The regulatory effects of second-generation antipsychotics on lipid metabolism: Potential mechanisms mediated by the gut microbiota and therapeutic implications
Hui Chen, Ting Cao, Bikui Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
豊田 隆謙, Xiaoyan He, Y. Liu, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 10
Predicting antipsychotic-induced weight gain in first episode psychosis – A field-wide systematic review and meta-analysis of non-genetic prognostic factors
Ita Fitzgerald, Laura J. Sahm, Amy Byrne, et al.
European Psychiatry (2023) Vol. 66, Iss. 1
Open Access | Times Cited: 10
Anti-Inflammatory Diets and Schizophrenia
Hee Shon Yun, Soo Jin Yang
Clinical Nutrition Research (2020) Vol. 9, Iss. 4, pp. 241-241
Open Access | Times Cited: 27
Effectiveness of nutrition and dietary interventions for people with serious mental illness: systematic review and meta‐analysis
Tetyana Rocks, Scott Teasdale, Caitlin Fehily, et al.
The Medical Journal of Australia (2022) Vol. 217, Iss. S7
Open Access | Times Cited: 15
Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance
Jaedeok Kim, Nayoung Lee, Sang Bum Suh, et al.
BMB Reports (2022) Vol. 55, Iss. 6, pp. 293-298
Open Access | Times Cited: 10
Olanzapine-Induced Activation of Hypothalamic Astrocytes and Toll-Like Receptor-4 Signaling via Endoplasmic Reticulum Stress Were Related to Olanzapine-Induced Weight Gain
Meng Xiao He, Kun Qian, Ying Zhang, et al.
Frontiers in Neuroscience (2021) Vol. 14
Open Access | Times Cited: 11
Vitamin D supplementation is effective for olanzapine-induced dyslipidemia
Zijian Zhou, Takuya Nagashima, Chihiro Toda, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Activation of the PERK-CHOP signaling pathway during endoplasmic reticulum stress contributes to olanzapine-induced dyslipidemia
Lu Liu, Lei Tang, Jiaming Luo, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 3, pp. 502-516
Closed Access | Times Cited: 4
The Effect of Accelerated Continuous Theta Burst Stimulation on Weight Loss in Overweight Individuals With Schizophrenia: A Double-Blind, Randomized, Sham-Controlled Clinical Trial
Dongyu Kang, Yi Zhang, Guowei Wu, et al.
Schizophrenia Bulletin (2023) Vol. 50, Iss. 3, pp. 589-599
Open Access | Times Cited: 4
Refeeding syndrome and psychopharmacological interventions in children and adolescents with Anorexia Nervosa: a focus on olanzapine-related modifications of electrolyte balance
Jacopo Pruccoli, Elena Barbieri, Caterina Visconti, et al.
European Journal of Pediatrics (2024) Vol. 183, Iss. 4, pp. 1935-1941
Open Access | Times Cited: 1
The Difficult Path to the Discovery of Novel Treatments in Psychiatric Disorders
Valentin K. Gribkoff, Leonard K. Kaczmarek
Advances in neurobiology (2023), pp. 255-285
Closed Access | Times Cited: 3
Clinical, physical, physiological, and cardiovascular risk patterns of adults with schizophrenia: CORTEX-SP study
Mikel Tous‐Espelosin, Sonia Ruiz de Azúa, Nagore Iriarte‐Yoller, et al.
Psychiatry Research (2020) Vol. 295, pp. 113580-113580
Closed Access | Times Cited: 7
Worth the Weight? Olanzapine Prescribing in Schizophrenia. A Review of Weight Gain and Other Cardiometabolic Side Effects of Olanzapine
Ita Fitzgerald, Sarah O’Dwyer, Margaret K. Brooks, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 6
Comparison of olanzapine-induced weight gain and metabolism abnormalities between topiramate and vitamin C in patients with schizophrenia: a preliminary study
Jinling Zhang, Shu Chen, Jia Chen, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 1
Hyperbaric oxygen exposure alleviate metabolic side-effects of olanzapine treatment and is associated with Langerhans islet proliferation in rats
Mohammad Alqudah, Mohammad Khalifeh, Rasha Al-Azaizeh, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 1
Risk of dyslipidaemia with antipsychotic drug treatment in Chinese inpatients with mental illness: a hospital-based cohort study
Qiuyue Ma, Fude Yang, Botao Ma, et al.
BMJ Open (2021) Vol. 11, Iss. 1, pp. e043259-e043259
Open Access
Page 1

Scroll to top